Showing 2341-2350 of 4065 results for "".
- Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectivenesshttps://reachmd.com/news/interim-estimates-of-2025-26-seasonal-influenza-vaccine-effectiveness/2486668/Key Takeaways In interim estimates, vaccine effectiveness against influenza-associated outpatient visits was 38%–41% in children and adolescents and 22%–34% in adults; effectiveness against influenza-associated hospitalization was 41% and 30%, respectively.
- NephCure Announces First-Ever IgA Nephropathy (IgAN) Awareness Day on September 26, 2024https://reachmd.com/news/nephcure-announces-first-ever-iga-nephropathy-igan-awareness-day-on-september-26-2024/2468134/PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- NephCure, a leading nonprofit organization dedicated to finding better treatments and a cure for rare kidney disease, is proud to announce the inaugural IgA Nephropathy (IgAN) Awareness Day on September 26, 2024. The event is specifically dedicated to r
- Plozasiran In FCS: PALISADE Phase 3 And 1-Year Extensionhttps://reachmd.com/news/plozasiran-in-fcs-palisade-phase-3-and-1-year-extension/2486871/Key Takeaways Plozasiran was associated with durable triglyceride lowering through month 24, with similar levels in participants treated during the blinded phase and those who later crossed over from placebo. ApoC3 fell substantially, and some particip
- Ozoralizumab Shows Serology-Independent Efficacy in Rheumatoid Arthritis, Expanding the Frontier of Fc-Free Anti-TNF Therapyhttps://reachmd.com/news/ozoralizumab-shows-serology-independent-efficacy-in-rheumatoid-arthritis-expanding-the-frontier-of-fc-free-anti-tnf-therapy/2483919/Despite significant advancements in the management of rheumatoid arthritis (RA), a large proportion of patients still fall short of remission or sustained disease control. Biologic and targeted synthetic DMARDs have reshaped therapeutic strategies, yet only a minority of patients—estimated
- 26-Year-Old Heart Transplant and Stroke Survivor Named National Champion for Women’s Healthhttps://reachmd.com/news/26-year-old-heart-transplant-and-stroke-survivor-named-national-champion-for-womens-health/2463067/DALLAS, May 13, 2024 — Fewer than half of all women are aware that heart disease is their leading cause of death. That is why the American Heart Association, celebrating one hundred years of lifesaving service, created its community-based Woman
- Study Finds Potential New Treatment Path for Lasting Lyme Disease Symptomshttps://reachmd.com/news/study-finds-potential-new-treatment-path-for-lasting-lyme-disease-symptoms/2462797/Expression levels of FGFRs from rhesus frontal cortex (FC) in response to live and non-viable B burgdorferi. FC tissue explants exposed to either live or sonicated B burg
- Extreme Heat Associated with Children's Asthma Hospital Visitshttps://reachmd.com/news/extreme-heat-associated-with-childrens-asthma-hospital-visits/2463112/Extreme heat associated with increased asthma hospital visits. Credit: ATS For children seeking care at a California
- How E-Visits are Streamlining Primary Carehttps://reachmd.com/news/how-e-visits-are-streamlining-primary-care/2484759/E-visits are resolving common outpatient problems while trimming downstream in-person care and improving clinic throughput, according to a large integrated-care analy
- The Role of RNA Editing in Regulating Neuroinflammation in Parkinson's Diseasehttps://reachmd.com/news/the-role-of-rna-editing-in-regulating-neuroinflammation-in-parkinsons-disease/2474443/Current research highlights that RNA editing enzymes, notably ADAR1, are integral in modulating inflammatory responses triggered by α-synuclein aggregates. Dysregulation in RNA editing emerges not only as an indic
- Gene Editing Advances for Stargardt Diseasehttps://reachmd.com/news/gene-editing-advances-stargardt-disease/2470897/What's New Groundbreaking research introduces a new gene editing technique that could revolutionize treatment for Stargardt disease, aiming to correct genetic mutations responsible for vision loss. Significance This development is significant because